The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Genes don’t affect response to anti-VEGF treatment
This analysis of data from the CATT and IVAN trials found no evidence that VEGFR2 genotypes affect response to anti-VEGF therapy in patients with wet AMD, contrary to a previous report.
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.